HMG-boxes, ribosomopathies and neurodegenerative disease
- PMID: 37600660
- PMCID: PMC10435976
- DOI: 10.3389/fgene.2023.1225832
HMG-boxes, ribosomopathies and neurodegenerative disease
Abstract
The UBTF E210K neuroregression syndrome is a predominantly neurological disorder caused by recurrent de novo dominant variants in Upstream Binding Factor, that is, essential for transcription of the ribosomal RNA genes. This unusual form of ribosomopathy is characterized by a slow decline in cognition, behavior, and sensorimotor functioning during the critical period of development. UBTF (or UBF) is a multi-HMGB-box protein that acts both as an epigenetic factor to establish "open" chromatin on the ribosomal genes and as a basal transcription factor in their RNA Polymerase I transcription. Here we review the possible mechanistic connections between the UBTF variants, ribosomal RNA gene transcription and the neuroregression syndrome, and suggest that DNA topology may play an important role.
Keywords: RNA polymerase I (POLR1); TBP-TAF complex SL1; UBTF-E210K; neuroregression syndrome; ribosome biogenesis; ribosomopathy; upstream binding factor (UBF/UBTF).
Copyright © 2023 Moss, LeDoux and Crane-Robinson.
Conflict of interest statement
Author ML was employed by company Veracity Neuroscience LLC. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
An Overview of UBTF Neuroregression Syndrome.Brain Sci. 2024 Feb 15;14(2):179. doi: 10.3390/brainsci14020179. Brain Sci. 2024. PMID: 38391753 Free PMC article. Review.
-
Ribosomal DNA promoter recognition is determined in vivo by cooperation between UBTF1 and SL1 and is compromised in the UBTF-E210K neuroregression syndrome.PLoS Genet. 2022 Feb 9;18(2):e1009644. doi: 10.1371/journal.pgen.1009644. eCollection 2022 Feb. PLoS Genet. 2022. PMID: 35139074 Free PMC article.
-
A recurrent de novo missense mutation in UBTF causes developmental neuroregression.Hum Mol Genet. 2018 Feb 15;27(4):691-705. doi: 10.1093/hmg/ddx435. Hum Mol Genet. 2018. PMID: 29300972 Free PMC article.
-
Behavioral and molecular effects of Ubtf knockout and knockdown in mice.Brain Res. 2022 Oct 15;1793:148053. doi: 10.1016/j.brainres.2022.148053. Epub 2022 Aug 13. Brain Res. 2022. PMID: 35973608 Free PMC article.
-
The chromatin landscape of the ribosomal RNA genes in mouse and human.Chromosome Res. 2019 Mar;27(1-2):31-40. doi: 10.1007/s10577-018-09603-9. Epub 2019 Jan 8. Chromosome Res. 2019. PMID: 30617621 Review.
Cited by
-
Polymerase I as a Target for Treating Neurodegenerative Disorders.Biomedicines. 2024 May 15;12(5):1092. doi: 10.3390/biomedicines12051092. Biomedicines. 2024. PMID: 38791054 Free PMC article. Review.
-
An Overview of UBTF Neuroregression Syndrome.Brain Sci. 2024 Feb 15;14(2):179. doi: 10.3390/brainsci14020179. Brain Sci. 2024. PMID: 38391753 Free PMC article. Review.
-
The Nucleolus: A Central Hub for Ribosome Biogenesis and Cellular Regulatory Signals.Int J Mol Sci. 2025 Apr 28;26(9):4174. doi: 10.3390/ijms26094174. Int J Mol Sci. 2025. PMID: 40362410 Free PMC article. Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources